Replimune Group's RP1 oncolytic virus therapy faced an FDA rejection, raising concerns about the platform's viability in ...

One great example of a “what the hell is happening here” story run just the other day that opened with, “Orange juice, known ...

One of the most notable accomplishments of the first Trump Administration was its willingness to take on the status quo of ...

Sarepta Therapeutics (SRPT) stock in focus as report says company hired a Trump-linked lobbying firm after deaths linked to ...

The amount of frozen funds could be as high as $200 million, or potentially more than $300 million, according to two ...

Overall, the initial steps of the wind-down will result the in the cancellation of nearly $500 million. Not all mRNA related ...

U.S. Defense Secretary Pete Hegseth announced Tuesday that a Confederate memorial would be reinstalled in Arlington Cemetery ...

The US Department of Health and Human Services has terminated 22 mRNA vaccine research contracts under BARDA, signaling a ...

Laura Loomer, a far-right activist once banned from social media, has become an influential, unofficial advisor to Donald ...

New evidence of effectiveness is cause to drop a Biden restriction on Medicare coverage for anti-amyloid treatments.

Laura Loomer has been dubbed “Trump’s Rasputin” as her influence grows with her quest to oust administration officials she ...

Eli Lilly said this morning that its experimental obesity pill orforglipron fell short of expectations in a late-stage trial, delivering 11.2% weight loss over 72 weeks — less than the 15% to 21% ...